戻る Agenda
Defining Clinical Trial Innovation: Challenges and Opportunities for 2013
Session Chair(s)
Susan K. Nunchuck, BSN, DRSC, PHD, MSN, RN
Senior Clinical Research Associate
Actelion Clinical Research, United States
Innovation to improve global health and meet unmet medical needs has challenges and opportunities. Given the regulated and increasingly resource-constrained R&D environment, are there opportunities for innovation to ensure a sustainable future? Panelists will debate and discuss the issues in this interactive forum.
This forum has been developed by the Clinical Research Community.
Learning Objective : Define clinical trial innovation in 2013; Identify key challenges and opportunities for innovation in clinical trials; Define funding resources in a constrained, highly regulated environment.
Speaker(s)
Panelist
Craig Lipset, MPH
Decentralized Trials & Research Alliance | Buffalo Initiative, United States
Co-Chair
Panelist
Andreas Koester, MD, PHD
Janssen Research & Development, LLC, United States
Vice President and Global Head, Clinical Innovation
Panelist
Jeffrey Kasher, PHD
Patients Can't Wait, LLC, United States
President